Log In
BCIQ
Print this Print this
 

NI-1201

  Manage Alerts
Collapse Summary General Information
Company Novimmune S.A.
DescriptionHuman mAb that neutralizes interleukin-6 (IL-6) receptor complex (IL-6RC) activity
Molecular Target Interleukin-6 (IL-6) receptor (CD126)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard Indication Autoimmune (unspecified)
Indication DetailsTreat autoimmune and inflammatory diseases
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today